UTAH MEDICAL PRODUCTS, INC. Amortization of Intangible Assets
UTAH MEDICAL PRODUCTS, INC. (UTMD) reported Amortization of Intangible Assets of $478.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-12
- UTAH MEDICAL PRODUCTS, INC. amortization of intangible assets for the quarter ending 2026-06-30 was $16.00K, a 97.03% decline year-over-year.
- UTAH MEDICAL PRODUCTS, INC. amortization of intangible assets for the quarter ending 2026-03-31 was $462.00K, a 9.23% decline year-over-year.
- UTAH MEDICAL PRODUCTS, INC. amortization of intangible assets for the quarter ending 2025-12-31 was $533.00K, a 3.09% increase year-over-year.
- UTAH MEDICAL PRODUCTS, INC. amortization of intangible assets for the quarter ending 2025-09-30 was $545.00K, a 3.81% increase year-over-year.
- UTAH MEDICAL PRODUCTS, INC. amortization of intangible assets for fiscal 2025 was $2.13M, a 2.95% increase from fiscal 2024.
- UTAH MEDICAL PRODUCTS, INC. amortization of intangible assets for fiscal 2024 was $2.06M, a 63.72% decline from fiscal 2023.
- UTAH MEDICAL PRODUCTS, INC. amortization of intangible assets for fiscal 2023 was $5.69M, a 11.30% decline from fiscal 2022.
- UTAH MEDICAL PRODUCTS, INC. amortization of intangible assets for fiscal 2022 was $6.42M, a 3.43% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $478.00K 10-Q · filed 2026-08-12 | $1.01M derived: sum of 3 quarters · filed 2026-08-12 | $1.56M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $462.00K 10-Q · filed 2026-05-12 | $995.00K derived: sum of 2 quarters · filed 2026-05-12 | $1.54M derived: sum of 3 quarters · filed 2026-05-12 | $2.08M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $533.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $1.08M derived: sum of 2 quarters · filed 2026-03-27 | $1.62M derived: sum of 3 quarters · filed 2026-08-12 | $2.13M 10-K · filed 2026-03-27 |
| 2025-09-30 | $545.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.08M derived: sum of 2 quarters · filed 2026-08-12 | $1.59M 10-Q · filed 2025-11-14 | $2.11M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $539.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $1.05M 10-Q · filed 2026-08-12 | $1.56M derived: sum of 3 quarters · filed 2026-08-12 | $2.09M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $509.00K 10-Q · filed 2026-05-12 | $1.03M derived: sum of 2 quarters · filed 2026-05-12 | $1.55M derived: sum of 3 quarters · filed 2026-05-12 | $2.06M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $517.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $1.04M derived: sum of 2 quarters · filed 2026-03-27 | $1.55M derived: sum of 3 quarters · filed 2026-03-27 | $2.06M 10-K · filed 2026-03-27 |
| 2024-09-30 | $525.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.03M derived: sum of 2 quarters · filed 2025-11-14 | $1.55M 10-Q · filed 2025-11-14 | $2.42M derived: sum of 4 quarters · filed 2026-03-27 |
| 2024-06-30 | $510.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.02M 10-Q · filed 2025-08-12 | $1.89M derived: sum of 3 quarters · filed 2026-03-27 | $3.51M derived: sum of 4 quarters · filed 2026-03-27 |
| 2024-03-31 | $513.00K 10-Q · filed 2025-05-15 | $1.38M derived: sum of 2 quarters · filed 2026-03-27 | $3.00M derived: sum of 3 quarters · filed 2026-03-27 | $4.61M derived: sum of 4 quarters · filed 2026-03-27 |
| 2023-12-31 | $868.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $2.48M derived: sum of 2 quarters · filed 2026-03-27 | $4.10M derived: sum of 3 quarters · filed 2026-03-27 | $5.69M 10-K · filed 2026-03-27 |
| 2023-09-30 | $1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $3.23M derived: sum of 2 quarters · filed 2024-11-12 | $4.82M 10-Q · filed 2024-11-12 | $6.40M derived: sum of 4 quarters · filed 2025-03-26 |
| 2023-06-30 | $1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $3.21M 10-Q · filed 2024-08-09 | $4.79M derived: sum of 3 quarters · filed 2025-03-26 | $6.37M derived: sum of 4 quarters · filed 2025-03-26 |
| 2023-03-31 | $1.60M 10-Q · filed 2024-05-10 | $3.18M derived: sum of 2 quarters · filed 2025-03-26 | $4.76M derived: sum of 3 quarters · filed 2025-03-26 | $6.37M derived: sum of 4 quarters · filed 2025-03-26 |
| 2022-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $3.16M derived: sum of 2 quarters · filed 2025-03-26 | $4.77M derived: sum of 3 quarters · filed 2025-03-26 | $6.42M 10-K · filed 2025-03-26 |
| 2022-09-30 | $1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $3.19M derived: sum of 2 quarters · filed 2023-11-13 | $4.84M 10-Q · filed 2023-11-13 | $6.49M derived: sum of 4 quarters · filed 2024-03-26 |
| 2022-06-30 | $1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $3.26M 10-Q · filed 2023-08-11 | $4.91M derived: sum of 3 quarters · filed 2024-03-26 | $6.57M derived: sum of 4 quarters · filed 2024-03-26 |
| 2022-03-31 | $1.65M 10-Q · filed 2023-05-05 | $3.29M derived: sum of 2 quarters · filed 2024-03-26 | $4.96M derived: sum of 3 quarters · filed 2024-03-26 | $6.63M derived: sum of 4 quarters · filed 2024-03-26 |
| 2021-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $3.31M derived: sum of 2 quarters · filed 2024-03-26 | $4.98M derived: sum of 3 quarters · filed 2024-03-26 | $6.64M 10-K · filed 2024-03-26 |
| 2021-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $3.33M derived: sum of 2 quarters · filed 2022-11-10 | $5.00M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $3.33M 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $1.66M 10-Q · filed 2022-05-11 | |||
| 2020-12-31 | $6.51M 10-K/A · filed 2023-03-28 | |||
| 2019-12-31 | $6.14M 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |